ACH
TCRR
ArrowMark Colorado Holdings’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-259,672
| Closed | -$467K | – | 336 |
|
|
2022
Q3 | $467K | Hold |
259,672
| – | – | 0.01% | 288 |
|
|
2022
Q2 | $753K | Hold |
259,672
| – | – | 0.01% | 275 |
|
|
2022
Q1 | $717K | Sell |
259,672
-168,416
| -39% | -$465K | 0.01% | 298 |
|
|
2021
Q4 | $2M | Sell |
428,088
-785,410
| -65% | -$3.66M | 0.02% | 269 |
|
|
2021
Q3 | $10.3M | Buy |
1,213,498
+186,370
| +18% | +$1.59M | 0.08% | 193 |
|
|
2021
Q2 | $16.9M | Buy |
1,027,128
+63,522
| +7% | +$1.04M | 0.13% | 145 |
|
|
2021
Q1 | $21.3M | Sell |
963,606
-203,614
| -17% | -$4.5M | 0.16% | 125 |
|
|
2020
Q4 | $36.1M | Sell |
1,167,220
-54,479
| -4% | -$1.69M | 0.28% | 91 |
|
|
2020
Q3 | $24.8M | Sell |
1,221,699
-134,311
| -10% | -$2.73M | 0.24% | 96 |
|
|
2020
Q2 | $20.8M | Sell |
1,356,010
-6,643
| -0.5% | -$102K | 0.22% | 98 |
|
|
2020
Q1 | $10.5M | Buy |
1,362,653
+92,887
| +7% | +$719K | 0.14% | 126 |
|
|
2019
Q4 | $18.1M | Buy |
1,269,766
+143,459
| +13% | +$2.05M | 0.16% | 119 |
|
|
2019
Q3 | $16.9M | Buy |
1,126,307
+640,975
| +132% | +$9.63M | 0.17% | 115 |
|
|
2019
Q2 | $6.95M | Buy |
485,332
+14,634
| +3% | +$209K | 0.07% | 187 |
|
|
2019
Q1 | $8.2M | Buy |
+470,698
| New | +$8.2M | 0.08% | 184 |
|